Outpatient 60‐hour day‐and‐night glucose control with dual‐hormone artificial pancreas, single‐hormone artificial pancreas, or sensor‐augmented pump therapy in adults with type 1 diabetes: An open‐label, randomised, crossover, controlled trial

DOI: 10.1111/dom.12880

,

Issn Print: 1462-8902

Publication Date: 2017/05/01

Ahmad Haidar; Virginie Messier; Laurent Legault; Martin Ladouceur; Rémi Rabasa‐Lhoret

Author Information: Faculty of Medicine, Department of Biomedical Engineering


		Checking for direct PDF access through Ovid

Abstract unavailable for this article.


		Loading Related Articles